Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.

Bazarbashi N, Ahuja K, Gad MM, Sammour YM, Kaur M, Karrthik A, Saad AM, Khubber S, Dhaliwal K, Mick SL, Navia JL, Puri R, Reed GW, Krishnaswamy A, Kapadia SR.

Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28585. [Epub ahead of print]

PMID:
31713996
2.

Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis.

Reed GW, Gerber RA, Shan Y, Takiya L, Dandreo KJ, Gruben D, Kremer J, Wallenstein G.

Rheumatol Ther. 2019 Nov 9. doi: 10.1007/s40744-019-00177-4. [Epub ahead of print]

3.

Unilateral Access Is Safe and Facilitates Peripheral Bailout During Transfemoral-Approach Transcatheter Aortic Valve Replacement.

Khubber S, Bazarbashi N, Mohananey D, Kadri A, Gad MM, Kaur M, Sammour YM, Lyden M, Ahuja KR, Verma B, Menon V, Mick SL, Reed GW, Puri R, Svensson L, Navia JL, Tuzcu EM, Krishnaswamy A, Kapadia SR.

JACC Cardiovasc Interv. 2019 Nov 11;12(21):2210-2220. doi: 10.1016/j.jcin.2019.06.050.

PMID:
31699379
4.

Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.

Gulati S, Pennington MW, Czerwinski A, Carter D, Zheng B, Nowak NA, DeOliveira RB, Shaughnessy J, Reed GW, Ram S, Rice PA.

mBio. 2019 Nov 5;10(6). pii: e02552-19. doi: 10.1128/mBio.02552-19.

5.

Meta-Analysis Comparing Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation With Versus Without Percutaneous Coronary Intervention.

Lateef N, Khan MS, Deo SV, Yamani N, Riaz H, Virk HUH, Khan SU, Hedrick DP, Kanaan A, Reed GW, Krishnaswamy A, Puri R, Kapadia SR, Kalra A.

Am J Cardiol. 2019 Dec 1;124(11):1757-1764. doi: 10.1016/j.amjcard.2019.08.024. Epub 2019 Sep 26.

PMID:
31575422
6.

The Impact of Hospital Characteristics on the Outcomes of Interventional Cardiac Procedures.

Gad MM, Ahuja KR, Bazarbashi N, Karrthik AK, Kaur M, Mick SL, Reed GW, Tuzcu EM, Krishnaswamy A, Kapadia SR.

JACC Cardiovasc Interv. 2019 Sep 23;12(18):1872-1874. doi: 10.1016/j.jcin.2019.05.033. No abstract available.

PMID:
31537295
7.

Outcomes of infliximab dose escalation in patients with rheumatoid arthritis.

Cohen SB, Kremer JM, Dandreo KJ, Reed GW, Magner R, Shan Y, Kafka S, DeHoratius RJ, Ellis L, Parenti D.

Clin Rheumatol. 2019 Sep;38(9):2501-2508. doi: 10.1007/s10067-019-04543-z. Epub 2019 May 2.

PMID:
31049762
8.

NSAID choice: lessons from PRECISION.

Reed GW, Nissen SE.

Aging (Albany NY). 2019 Apr 29;11(8):2181-2182. doi: 10.18632/aging.101930. No abstract available.

9.

Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance.

Li Y, Su X, Le W, Li S, Yang Z, Chaisson C, Madico G, Gong X, Reed GW, Wang B, Rice PA.

Clin Infect Dis. 2019 Apr 11. pii: ciz294. doi: 10.1093/cid/ciz294. [Epub ahead of print]

PMID:
30972419
10.

Angiographic predictors of adverse outcomes after percutaneous coronary intervention in patients with radiation associated coronary artery disease.

Reed GW, Rossi JE, Masri A, Griffin BP, Ellis SG, Kapadia SR, Desai MY.

Catheter Cardiovasc Interv. 2019 Sep 1;94(3):E104-E110. doi: 10.1002/ccd.28107. Epub 2019 Jan 28.

PMID:
30690850
11.

Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.

Lillegraven S, Greenberg JD, Reed GW, Saunders K, Curtis JR, Harrold L, Hochberg MC, Pappas DA, Kremer JM, Solomon DH.

PLoS One. 2019 Jan 23;14(1):e0210459. doi: 10.1371/journal.pone.0210459. eCollection 2019.

12.

Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry.

Mease PJ, Palmer JB, Hur P, Strober BE, Lebwohl M, Karki C, Reed GW, Etzel CJ, Greenberg JD, Helliwell PS.

J Eur Acad Dermatol Venereol. 2019 May;33(5):886-892. doi: 10.1111/jdv.15443. Epub 2019 Mar 5.

13.

Can we trust observational data for clinical decision-making?

Nissen SE, Reed GW.

Eur Heart J. 2019 May 7;40(18):1408-1410. doi: 10.1093/eurheartj/ehy874. No abstract available.

PMID:
30597016
14.

Refining Coronary Stent Platforms in the Modern DES Era: Thinning, Eluting, Inhibiting, and Absorbing.

Puri R, Reed GW.

J Am Coll Cardiol. 2018 Dec 25;72(25):3298-3300. doi: 10.1016/j.jacc.2018.10.033. No abstract available.

15.

Operational Efficiency and Effective Management in the Catheterization Laboratory: JACC Review Topic of the Week.

Reed GW, Tushman ML, Kapadia SR.

J Am Coll Cardiol. 2018 Nov 13;72(20):2507-2517. doi: 10.1016/j.jacc.2018.08.2179. Review.

16.

Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis.

Harrold LR, Reed GW, Best J, Zlotnick S, Kremer JM.

Rheumatol Ther. 2018 Dec;5(2):507-523. doi: 10.1007/s40744-018-0127-1. Epub 2018 Oct 6.

17.

Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against Neisseria gonorrhoeae.

Shaughnessy J, Lewis LA, Zheng B, Carr C, Bass I, Gulati S, DeOliveira RB, Gose S, Reed GW, Botto M, Rice PA, Ram S.

J Immunol. 2018 Nov 1;201(9):2700-2709. doi: 10.4049/jimmunol.1701666. Epub 2018 Sep 28.

18.

Percutaneous coronary intervention for stable angina in ORBITA.

Reed GW, Kapadia SR.

Lancet. 2018 Jul 7;392(10141):27-28. doi: 10.1016/S0140-6736(18)31187-5. Epub 2018 Jul 5. No abstract available.

PMID:
30047393
19.

A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.

Ram S, Gulati S, Lewis LA, Chakraborti S, Zheng B, DeOliveira RB, Reed GW, Cox AD, Li J, St Michael F, Stupak J, Su XH, Saha S, Landig CS, Varki A, Rice PA.

Infect Immun. 2018 Jul 23;86(8). pii: e00285-18. doi: 10.1128/IAI.00285-18. Print 2018 Aug.

20.

Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study.

Pappas DA, Nyberg F, Kremer JM, Lampl K, Reed GW, Horne L, Ho M, Onofrei A, Malaviya AN, Rillo OL, Radominski SC, Gal J, Gibofsky A, Popkova TV, Laurindo L, Kerzberg EM, Zahora R, Pons-Estel BA, Curtis JR, Furst DE, Greenberg JD.

Clin Rheumatol. 2018 Sep;37(9):2331-2340. doi: 10.1007/s10067-018-4113-3. Epub 2018 Apr 25.

PMID:
29696436
21.

Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.

Reed GW, Abdallah MS, Shao M, Wolski K, Wisniewski L, Yeomans N, Lüscher TF, Borer JS, Graham DY, Husni ME, Solomon DH, Libby P, Menon V, Lincoff AM, Nissen SE.

J Am Coll Cardiol. 2018 Apr 24;71(16):1741-1751. doi: 10.1016/j.jacc.2018.02.036.

22.

Operational Efficiency and Productivity Improvement Initiatives in a Large Cardiac Catheterization Laboratory.

Reed GW, Hantz S, Cunningham R, Krishnaswamy A, Ellis SG, Khot U, Rak J, Kapadia SR.

JACC Cardiovasc Interv. 2018 Feb 26;11(4):329-338. doi: 10.1016/j.jcin.2017.09.025. Epub 2018 Feb 1.

23.

Cutting Edge: Plasmodium falciparum Induces Trained Innate Immunity.

Schrum JE, Crabtree JN, Dobbs KR, Kiritsy MC, Reed GW, Gazzinelli RT, Netea MG, Kazura JW, Dent AE, Fitzgerald KA, Golenbock DT.

J Immunol. 2018 Feb 15;200(4):1243-1248. doi: 10.4049/jimmunol.1701010. Epub 2018 Jan 12.

24.

Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study.

Larmore CJ, Boytsov NN, Gaich CL, Zhang X, Araujo AB, Rebello S, Salim BA, Reed GW, Harrold LR.

Rheumatol Ther. 2018 Jun;5(1):215-229. doi: 10.1007/s40744-017-0092-0. Epub 2018 Jan 10.

25.

Hemodynamic Assessment Before and After Endovascular Therapy for Critical Limb Ischemia and Association With Clinical Outcomes.

Reed GW, Young L, Bagh I, Maier M, Shishehbor MH.

JACC Cardiovasc Interv. 2017 Dec 11;10(23):2451-2457. doi: 10.1016/j.jcin.2017.06.063. Epub 2017 Nov 15.

26.

Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis.

Harrold LR, John A, Reed GW, Haselkorn T, Karki C, Li Y, Best J, Zlotnick S, Kremer JM, Greenberg JD.

Rheumatol Ther. 2017 Dec;4(2):405-417. doi: 10.1007/s40744-017-0081-3. Epub 2017 Sep 21.

27.

Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long-Term Mortality After Noncardiac Vascular Surgery.

Reed GW, Horr S, Young L, Clevenger J, Malik U, Ellis SG, Lincoff AM, Nissen SE, Menon V.

J Am Heart Assoc. 2017 Jun 6;6(6). pii: e005672. doi: 10.1161/JAHA.117.005672.

28.

STREAM characterisation correction - Authors' reply.

Reed GW, Cannon CP.

Lancet. 2017 May 27;389(10084):2102-2103. doi: 10.1016/S0140-6736(17)31336-3. No abstract available.

PMID:
28561001
29.

Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis.

Harrold LR, Reed GW, John A, Barr CJ, Soe K, Magner R, Saunders KC, Ruderman EM, Haselkorn T, Greenberg JD, Gibofsky A, Harrington JT, Kremer JM.

Arthritis Care Res (Hoboken). 2018 Mar;70(3):379-387. doi: 10.1002/acr.23294. Epub 2018 Feb 6.

30.

Prevalence of Tibial Artery and Pedal Arch Patency by Angiography in Patients With Critical Limb Ischemia and Noncompressible Ankle Brachial Index.

Randhawa MS, Reed GW, Grafmiller K, Gornik HL, Shishehbor MH.

Circ Cardiovasc Interv. 2017 May;10(5). pii: e004605. doi: 10.1161/CIRCINTERVENTIONS.116.004605.

PMID:
28468953
31.

Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis.

Reed GW, Collier DH, Koenig AS, Saunders KC, Pappas DA, Litman HJ, Kremer JM, Kotak S.

Arthritis Res Ther. 2017 Apr 27;19(1):81. doi: 10.1186/s13075-017-1289-x.

32.

Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry.

Kavanaugh A, Keystone E, Greenberg JD, Reed GW, Griffith JM, Friedman AW, Saunders KC, Ganguli A.

Rheumatology (Oxford). 2017 Jul 1;56(7):1095-1101. doi: 10.1093/rheumatology/kex042.

PMID:
28340006
33.

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry.

Harrold LR, Reed GW, Solomon DH, Curtis JR, Liu M, Greenberg JD, Kremer JM.

Arthritis Res Ther. 2016 Dec 1;18(1):280.

34.

Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry.

Pappas DA, John A, Curtis JR, Reed GW, Karki C, Magner R, Kremer JM, Shewade A, Greenberg JD.

Rheumatol Ther. 2016 Jun;3(1):103-115. doi: 10.1007/s40744-016-0028-0. Epub 2016 Feb 8.

35.

Acute myocardial infarction.

Reed GW, Rossi JE, Cannon CP.

Lancet. 2017 Jan 14;389(10065):197-210. doi: 10.1016/S0140-6736(16)30677-8. Epub 2016 Aug 5. Review. Erratum in: Lancet. 2017 Jan 14;389(10065):156.

PMID:
27502078
36.

Troponin Elevation After Colorectal Surgery: Significance and Management.

Gorgun E, Lan BY, Aydinli HH, Reed GW, Menon V, Sessler DI, Stocchi L, Remzi FH.

Ann Surg. 2016 Oct;264(4):605-11. doi: 10.1097/SLA.0000000000001854.

PMID:
27433900
37.

A Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response Modifiers.

Rathbun AM, Harrold LR, Reed GW.

Clin Ther. 2016 Jul;38(7):1759-1772.e3. doi: 10.1016/j.clinthera.2016.06.007. Epub 2016 Jun 29.

38.

Time to Wound Healing and Major Adverse Limb Events in Patients with Critical Limb Ischemia Treated with Endovascular Revascularization.

Reed GW, Salehi N, Giglou PR, Kafa R, Malik U, Maier M, Shishehbor MH.

Ann Vasc Surg. 2016 Oct;36:190-198. doi: 10.1016/j.avsg.2016.02.032. Epub 2016 Jun 25.

PMID:
27354323
39.

Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated With Percutaneous Coronary Intervention.

Reed GW, Masri A, Griffin BP, Kapadia SR, Ellis SG, Desai MY.

Circ Cardiovasc Interv. 2016 Jun;9(6). pii: e003483. doi: 10.1161/CIRCINTERVENTIONS.115.003483.

PMID:
27313281
40.

Hospital Readmissions Following Endovascular Therapy for Critical Limb Ischemia: Associations With Wound Healing, Major Adverse Limb Events, and Mortality.

Reed GW, Raeisi-Giglou P, Kafa R, Malik U, Salehi N, Shishehbor MH.

J Am Heart Assoc. 2016 May 20;5(5). pii: e003168. doi: 10.1161/JAHA.115.003168.

41.

Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry.

Harrold LR, Reed GW, Karki C, Magner R, Shewade A, John A, Kremer JM, Greenberg JD.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1888-1893. doi: 10.1002/acr.22912.

42.

Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial.

Reed GW, Cannon CP, Waalen J, Teirstein PS, Tanguay JF, Berger PB, Angiolillo DJ, Price MJ.

Catheter Cardiovasc Interv. 2017 Feb 1;89(2):190-198. doi: 10.1002/ccd.26428. Epub 2016 Feb 23.

PMID:
26909669
43.

A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.

Shaughnessy J, Gulati S, Agarwal S, Unemo M, Ohnishi M, Su XH, Monks BG, Visintin A, Madico G, Lewis LA, Golenbock DT, Reed GW, Rice PA, Ram S.

J Immunol. 2016 Feb 15;196(4):1732-40. doi: 10.4049/jimmunol.1500292. Epub 2016 Jan 15.

44.

Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.

Gulati S, Schoenhofen IC, Whitfield DM, Cox AD, Li J, St Michael F, Vinogradov EV, Stupak J, Zheng B, Ohnishi M, Unemo M, Lewis LA, Taylor RE, Landig CS, Diaz S, Reed GW, Varki A, Rice PA, Ram S.

PLoS Pathog. 2015 Dec 2;11(12):e1005290. doi: 10.1371/journal.ppat.1005290. eCollection 2015 Dec.

45.
46.

The Effect of Post-Exercise Ankle-Brachial Index on Lower Extremity Revascularization.

Hammad TA, Strefling JA, Zellers PR, Reed GW, Venkatachalam S, Lowry AM, Gornik HL, Bartholomew JR, Blackstone EH, Shishehbor MH.

JACC Cardiovasc Interv. 2015 Aug 17;8(9):1238-1244. doi: 10.1016/j.jcin.2015.04.021.

47.

Authors' Reply.

Reed GW, Guo J, Cannon CP, Kumar A, Aranki S, Shekar P, Agnihotri A, Maree AO, McLean DS, Rosenfield K.

Clin Cardiol. 2015 Jul;38(7):444-5. doi: 10.1002/clc.22413. No abstract available.

48.

Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population.

Pappas DA, Reed GW, Saunders K, John A, Shewade A, Greenberg JD, Kremer JM.

Rheumatol Ther. 2015 Jun;2(1):85-96. Epub 2015 Jan 27.

49.

Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry.

Harrold LR, Reed GW, Shewade A, Magner R, Saunders KC, John A, Kremer JM, Greenberg JD.

J Rheumatol. 2015 Jul;42(7):1090-8. doi: 10.3899/jrheum.141043. Epub 2015 May 1.

50.

Disease activity in rheumatoid arthritis and the risk of cardiovascular events.

Solomon DH, Reed GW, Kremer JM, Curtis JR, Farkouh ME, Harrold LR, Hochberg MC, Tsao P, Greenberg JD.

Arthritis Rheumatol. 2015 Jun;67(6):1449-55. doi: 10.1002/art.39098.

Supplemental Content

Support Center